Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Tech Coloproctol ; 28(1): 32, 2024 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-38349559

RESUMO

BACKGROUND: Evidence on early closure (EC) of defunctioning stoma (DS) after colorectal surgery shows a favorable effect when patients are carefully selected. Therefore, a clinical pathway adapted to the implementation of an EC strategy was developed in our center. The aim of this study was to carry out a comparative analysis of time until DS closure and DS-related morbidity before and after the implementation of an EC protocol (ECP). METHODS: This study is a before-and-after comparative analysis. Patients were divided into two cohorts according to the observational period: patients from the period before the ECP implementation (January 2015-December 2019) [Period 1] and those from the period after that (January 2020-December 2022) [Period 2]. All consecutive patients subjected to elective DS closure within both periods were eligible. Early closure was defined as the reversal within 30 days from DS creation. Patients excluded from EC or those not closed within 30 days since primary surgery were analyzed as late closure (LC). Baseline characteristics and DS-related morbidity were recorded. RESULTS: A total of 145 patients were analyzed. Median time with DS was shorter in patients after ECP implementation [42 (21-193) days versus 233 (137-382) days, p < 0.001]. This reduction in time to closure did not impact the DS closure morbidity and resulted in less DS morbidity (68.8% versus 49.2%, p = 0.017) and fewer stoma nurse visits (p = 0.029). CONCLUSIONS: The ECP was able to significantly reduce intervals to restoration of bowel continuity in patients with DS, which in turn resulted in a direct impact on the reduction of DS morbidity without negatively affecting DS closure morbidity.


Assuntos
Cirurgia Colorretal , Estomas Cirúrgicos , Humanos , Estomas Cirúrgicos/efeitos adversos , Centros de Atenção Terciária
2.
BMC Cancer ; 23(1): 271, 2023 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-36964485

RESUMO

OBJECTIVES: To evaluate the effectiveness of an innovative supervised exercise programme to mitigate the loss of lean body mass, functional capacity and quality of life in people with head and neck cancer, as well as to identify the optimal moment to apply it, before or after radiotherapy treatment, compared with the prescription of a physical activity plan carried out autonomously. METHODS: Patients with squamous cell carcinoma of the head and neck (n = 144), treated with radiotherapy, will be randomly assigned to one of 3 comparison groups: pre-radiotherapy supervised exercise, post-radiotherapy supervised exercise and autonomous exercise, stratifying by human papillomavirus infection and previous surgery. The exercise programme will be carried out in 36 sessions over 12 weeks, combining moderate and high intensity strength and aerobic exercises. The main outcome variable is the change in lean body mass at 6 months measured by bioimpedance, while secondary variables are functional capacity, symptoms, quality of life and adverse effects. Longitudinal generalised mixed models will be used for the analyses of the repeated measurements at 3, 6, and 12 months after baseline. CONCLUSIONS: The pilot study supports the feasibility and safety of the project. However, as the programme progressed, attendance at the sessions decreased. Strategies will be necessary for increasing attendance, as well as involving the patient in their recovery and other incentives. Follow-up after treatment to assess acute/late toxicity will enable us to know the response to both the exercise programme and its adherence. TRIAL REGISTRATION: NCT04658706 Date and version identifier: March 1, 2023. Version 1.1.


Assuntos
Terapia por Exercício , Neoplasias de Cabeça e Pescoço , Humanos , Terapia por Exercício/métodos , Qualidade de Vida , Projetos Piloto , Exercício Físico , Neoplasias de Cabeça e Pescoço/terapia , Ensaios Clínicos Controlados Aleatórios como Assunto
3.
Water Sci Technol ; 77(3-4): 714-720, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29431716

RESUMO

A membrane bioreactor (MBR) and a hybrid moving bed biofilm reactor-membrane bioreactor (hybrid MBBR-MBR) for municipal wastewater treatment were studied to determine the effect of salinity on nitrogen removal and autotrophic kinetics. The biological systems were analyzed during the start-up phase with a hydraulic retention time (HRT) of 6 h, total biomass concentration of 2,500 mg L-1 in the steady state, and electric conductivities of 1.05 mS cm-1 for MBR and hybrid MBBR-MBR working under regular salinity and conductivity variations of 1.2-6.5 mS cm-1 for MBR and hybrid MBBR-MBR operating at variable salinity. The variable salinity affected the autotrophic biomass, which caused a reduction of the nitrogen degradation rate, an increase of time to remove ammonium from municipal wastewater and longer duration of the start-up phase for the MBR and hybrid MBBR-MBR.


Assuntos
Reatores Biológicos , Salinidade , Eliminação de Resíduos Líquidos/métodos , Poluentes Químicos da Água/metabolismo , Compostos de Amônio/metabolismo , Biofilmes , Biomassa , Condutividade Elétrica , Cinética , Membranas Artificiais , Nitrogênio/metabolismo , Águas Residuárias
4.
Ann Oncol ; 27(4): 706-11, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26658889

RESUMO

BACKGROUND: Patients with metastatic renal carcinoma (mRCC) treated with first-line pazopanib were not included in the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model. SPAZO (NCT02282579) was a nation-wide retrospective observational study designed to assess the effectiveness and validate the IMDC prognostic model in patients treated with first-line pazopanib in clinical practice. PATIENTS AND METHODS: Data of 278 patients, treated with first-line pazopanib for mRCC in 34 centres in Spain, were locally recorded and externally validated. Mean age was 66 years, there were 68.3% male, 93.5% clear-cell type, 74.8% nephrectomized, and 81.3% had ECOG 0-1. Metastatic sites were: lung 70.9%, lymph node 43.9%, bone 26.3%, soft tissue/skin 20.1%, liver 15.1%, CNS 7.2%, adrenal gland 6.5%, pleura/peritoneum 5.8%, pancreas 5%, and kidney 2.2%. After median follow-up of 23 months, 76.4% had discontinued pazopanib (57.2% due to progression), 47.9% had received second-line targeted therapy, and 48.9% had died. RESULTS: According to IMDC prognostic model, 19.4% had favourable risk (FR), 57.2% intermediate risk (IR), and 23.4% poor risk (PR). No unexpected toxicities were recorded. Response rate was 30.3% (FR: 44%, IR: 30% PR: 17.3%). Median progression-free survival (whole population) was 11 months (32 in FR, 11 in IR, 4 in PR). Median and 2-year overall survival (whole population) were 22 months and 48.1%, respectively (FR: not reached and 81.6%, IR: 22 and 48.7%, PR: 7 and 18.8%). These estimations and their 95% confidence intervals are fully consistent with the outcomes predicted by the IMDC prognostic model. CONCLUSION: Our results validate the IMDC model for first-line pazopanib in mRCC and confirm the effectiveness and safety of this treatment.


Assuntos
Carcinoma de Células Renais/tratamento farmacológico , Terapia de Alvo Molecular , Prognóstico , Pirimidinas/administração & dosagem , Sulfonamidas/administração & dosagem , Adulto , Idoso , Carcinoma de Células Renais/patologia , Bases de Dados Factuais , Intervalo Livre de Doença , Feminino , Humanos , Indazóis , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Pirimidinas/efeitos adversos , Estudos Retrospectivos , Fatores de Risco , Espanha , Sulfonamidas/efeitos adversos
5.
Biofouling ; 31(4): 333-48, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26000766

RESUMO

A bench-scale pure moving bed bioreactor-membrane bioreactor (MBBR-MBR) used for the treatment of urban wastewater was analyzed for the identification of bacterial strains with the potential capacity for calcium carbonate and struvite biomineral formation. Isolation of mineral-forming strains on calcium carbonate and struvite media revealed six major colonies with a carbonate or struvite precipitation capacity in the biofouling on the membrane surface and showed that heterotrophic bacteria with the ability to precipitate calcium carbonate and struvite constituted ~7.5% of the total platable bacteria. These belonged to the genera Lysinibacillus, Trichococcus, Comamomas and Bacillus. Pyrosequencing analysis of the microbial communities in the suspended cells and membrane biofouling showed a high degree of similarity in all the samples collected with respect to bacterial assemblage. The study of operational taxonomic units (OTUs) identified through pyrosequencing suggested that ~21% of the total bacterial community identified in the biofouling could potentially form calcium carbonate or struvite crystals in the pure MBBR-MBR system used for the treatment of urban wastewater.


Assuntos
Bactérias/classificação , Incrustação Biológica , Reatores Biológicos/microbiologia , Carbonato de Cálcio/química , Compostos de Magnésio/química , Metagenômica , Fosfatos/química , Bactérias/genética , Bactérias/isolamento & purificação , Biofilmes/crescimento & desenvolvimento , Membranas Artificiais , Estruvita , Águas Residuárias/química , Águas Residuárias/microbiologia
6.
J Dairy Sci ; 93(12): 5552-60, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21094727

RESUMO

Lactobacillus casei is a lactic acid bacterium (LAB) that colonizes diverse ecological niches and that has found broad commercial application. The aim of this study was to characterize the kinetics of biomass production, lactic acid production, and substrate consumption of Lactobacillus casei var. rhamnosus cultured in deproteinized milk whey. Batch culture experiments were performed in an instrumented, 2-L, stirred tank bioreactor using different inoculum concentrations (0.5 to 1.0 g/L) and lactose levels (35 to 70 g/L). The time series of experimental data corresponding to biomass growth, lactose consumption, and lactic acid formation were differentiated to calculate the corresponding kinetic rates. Strong exponentially dependent product inhibition effects were evident at low lactic acid concentrations, and lactic acid production rate was partially associated with biomass growth. A mathematical model is presented that reproduces the experimental lactose, biomass, and lactic acid concentration profiles.


Assuntos
Ácido Láctico/biossíntese , Lacticaseibacillus casei/crescimento & desenvolvimento , Lacticaseibacillus casei/metabolismo , Leite/microbiologia , Animais , Biomassa , Reatores Biológicos , Meios de Cultura/metabolismo , Cinética , Lactose/análise , Leite/química , Proteínas do Leite , Modelos Biológicos , Proteínas do Soro do Leite
7.
Neurologia (Engl Ed) ; 35(4): 226-232, 2020 May.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29162287

RESUMO

INTRODUCTION: Children with congenital hypothyroidism (CH) are at risk of developing mild cognitive impairment despite normal overall intellectual performance. These deficits may be caused by disease-related and treatment-related factors. This study explores the impact of abnormal thyroid function during the first 3 years of life on attention performance at school age. METHODS: We included 49 children diagnosed with CH and receiving treatment for the condition: 14 boys (mean age 9.5±2.8 years) and 35 girls (9.6±2.6 years). The number of episodes of normal, under-, and overtreatment were estimated based on TSH levels during their first 3 years of life (at 12, 18, 24, 30, and 36 months). Children were assessed using a computerised version of a Sustained attention test. General linear models were calculated with the attention index as the dependent variable and sex, aetiology, and number of episodes of normal, under-, and overtreatment as independent variables. RESULTS: Higher numbers of episodes of overtreatment (low TSH level) were associated with poorer attention performance at school age (P=.005, r=-0.45). CONCLUSIONS: Children with CH should be monitored closely during the first 3 years of life in order to prevent not only hypothyroidism but also any adverse effects of overtreatment that may affect attentional function at school age.


Assuntos
Atenção/fisiologia , Hipotireoidismo Congênito/tratamento farmacológico , Uso Excessivo dos Serviços de Saúde , Tireotropina/análise , Tiroxina/uso terapêutico , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Instituições Acadêmicas , Espanha
8.
An Pediatr (Barc) ; 71(3): 240-3, 2009 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-19625225

RESUMO

INTRODUCTION: A high prevalence of parietal cell antibodies (PCA) has been reported in children with autoimmune thyroid disease (AITD). The aim of this study was to determine the prevalence of autoimmune gastritis markers among children diagnosed as AITD. PATIENTS AND METHODS: We studied 26 patients with AITD. Basal samples were taken to determine: hemogram, vitamin B12 and folic acid plasmatic levels, gastrin plasmatic levels, and PCA's determination. Other autoimmune disease comorbidity were also studied. RESULTS: Free T4 and TSH values were normal, with hormonal substitutive treatment. Hb, MCV, HCM, vitamin B12, folic acid and gastrin were in normal range for all 26 patients. We reported 6 cases diabetes mellitus type 1 and 2 of celiac disease. A single patient was PCA positive. It was a 14-year-old hyperthyroid girl without any other autoimmune disease. CONCLUSIONS: AITD in childhood and adolescence is associated with other autoimmune diseases, specially DM1 and CD. PCA becomes an early and sensitive marker to detect autoimmune gastritis.


Assuntos
Doenças Autoimunes/complicações , Gastrite/complicações , Gastrite/imunologia , Doenças da Glândula Tireoide/complicações , Doenças da Glândula Tireoide/imunologia , Adolescente , Doenças Autoimunes/epidemiologia , Criança , Estudos Transversais , Feminino , Gastrite/epidemiologia , Humanos , Masculino , Prevalência , Estudos Prospectivos , Adulto Jovem
9.
Cir Pediatr ; 21(2): 100-3, 2008 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-18624279

RESUMO

PURPOSE: To emphasize the importance of genetic studies in family members and early prophylactic thyroidectomy in oncogene mutation carriers in the management of familiar medullary thyroid carcinoma. METHODS: A retrospective review of families with familiar medullary thyroid carcinoma treated at our center in the last 7 years was performed. We identified a total of 7 families who has isolated prevalences with thyroid malignancies. Forty members of the 7 families were screened for gene RET mutations. Prophylactic total thyroidectomy was performed in every RET mutation gene carriers. RESULTS: In all families the index case were patients with medullary thyroid carcinoma presenting at a mean age of 37.25 years (range 23-42). The RET oncogen mutation was in codon 634 in exon 11 (multiple endocrine neoplasia type 2A) in all these patients. Fourteen gene carriers were identified with a mean age of 20 years (range 7-37), eleven of whom had medullary thyroid carcinoma at the time of surgery. Five of the gene carriers were children, with a mean age of 11 years (range 7-16), four of whom had microcarcinoma and one had metastatic carcinoma at the time of surgery. After surgery no hypoparathyroidism or recurrent nerve paralysis were documented. No pediatric patient has presented with phaeochromocytoma or hypoparathyroidism to date Four of the five children have normal calcitonin levels (< 2 pg/ml) and they are free of disease. The one who presented metastatic carcinoma has recurrent disease and is awaiting surgical treatment. CONCLUSIONS: Genetic studies of family members related to patients with familiar medullary thyroid carcinoma and RET mutations is indispensable. The RET mutation in codon 634 exon 11 was found to be the most frequent association. Prophylactic thyroidectomy is the only curative treatment and has minimal complications when performed by expert surgeons. Early thyroidectomy is recommended since distant metastatic spread can occur at early age.


Assuntos
Carcinoma Medular/prevenção & controle , Neoplasias da Glândula Tireoide/prevenção & controle , Tireoidectomia , Adolescente , Adulto , Carcinoma Medular/genética , Criança , Humanos , Estudos Retrospectivos , Neoplasias da Glândula Tireoide/genética
10.
Ann R Coll Surg Engl ; 99(2): e91-e93, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27917670

RESUMO

Tailgut cysts are rare benign retrorectal cysts arising from persistent remnants of an embryonic hindgut. Malignant transformation inside this lesion is very uncommon and occurrence of neuroendocrine tumours in this context is extremely rare. We report the case of a 56-year-old woman who underwent surgical excision of a presacral tailgut cyst, which was found incidentally to include a neuroendocrine tumour.


Assuntos
Cistos , Hamartoma , Tumores Neuroendócrinos , Cistos/complicações , Cistos/diagnóstico por imagem , Cistos/cirurgia , Feminino , Hamartoma/complicações , Hamartoma/diagnóstico por imagem , Hamartoma/cirurgia , Humanos , Pessoa de Meia-Idade , Tumores Neuroendócrinos/complicações , Tumores Neuroendócrinos/diagnóstico por imagem , Tumores Neuroendócrinos/cirurgia , Fístula Retal/etiologia , Reto/diagnóstico por imagem , Reto/cirurgia , Sacro/diagnóstico por imagem , Sacro/cirurgia
11.
J Pediatr Endocrinol Metab ; 18 Suppl 1: 1237-44, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16398454

RESUMO

Neuroendocrine tumours constitute a heterogeneous association of neoplasms, originated from a common precursor cell population. They include endocrine glands, such as the pituitary, the parathyroids, the cells of the neuroendocrine adrenals, endocrine islets within glandular tissue (thyroid, pancreas) and dispersed cells (diffuse endocrine system). Neuroendocrine tumours can occur sporadically or in a familial context, such as multiple endocrine neoplasia (MEN) syndromes. These are inherited autosomal dominant cancer syndromes, transmitted with 100% penetrance. They are categorized into MEN type 1 and type 2. The dream of each physician who treats cancer is to develop a strategy that will have a significantly favourable impact on morbidity and mortality associated with malignant tumours. This has been achieved as a result of improved screening and early treatment strategies in MEN. MEN 2 and medullary thyroid carcinoma (MTC) are of special relevance in childhood, because they require urgent and early diagnosis and treatment. The explication of the genetic basis of MTC has revolutionised management of the familial forms of this tumour.


Assuntos
Neoplasia Endócrina Múltipla/patologia , Carcinoma Medular/genética , Carcinoma Medular/patologia , Carcinoma Medular/cirurgia , Criança , Pré-Escolar , Testes Genéticos , Humanos , Neoplasia Endócrina Múltipla/genética , Neoplasia Endócrina Múltipla/cirurgia , Feocromocitoma/genética , Feocromocitoma/patologia , Neoplasias Hipofisárias/genética , Neoplasias Hipofisárias/patologia , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/cirurgia , Tireoidectomia
12.
Eur Cytokine Netw ; 14(1): 65-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12799216

RESUMO

OBJECTIVE: To analyse the production of TNF-alpha and NO in euthyroid and hypothyroid newborns. PATIENTS: A cross-sectional study was conducted involving 10 newborns diagnosed with primary congenital hypothyroidism (CH; group A) and 10 euthyroid children (group B). RESULTS: There were undetectable plasma levels of TNF-alpha and NO in the hypothyroid children, however plasma levels of TNF-alpha (5.5 0.5 pg/ml) and NO (5.6 1.7 microM) were detected at normal levels in all euthyroid children. Moreover, expression of iNOS mRNA in PBMC, determined by RT-PCR, was negative in both groups of infants. CONCLUSION: TNF-alpha and NO production are both impaired in hypothyroid newborns. We report for the first time evidence of undetectable levels of TNF-alpha and NO in infants with CH.


Assuntos
Hipotireoidismo Congênito , Hipotireoidismo/imunologia , Óxido Nítrico Sintase/sangue , Óxido Nítrico/sangue , Fator de Necrose Tumoral alfa/análise , Adulto , Sequência de Bases , Estudos Transversais , Primers do DNA , Humanos , Hipotireoidismo/enzimologia , Recém-Nascido , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Reação em Cadeia da Polimerase/métodos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sensibilidade e Especificidade , Fator de Necrose Tumoral alfa/genética
14.
Acta Otorrinolaringol Esp ; 41(2): 111-3, 1990.
Artigo em Espanhol | MEDLINE | ID: mdl-2390294

RESUMO

We display a case of a female patient with a pleomorphic adenoma localized in the nasal fossa, with 10 years of evolution and that has been extirpated by an external way. We review the bibliography, we emphasize the rareness of the locality and make considerations about clinic, prognostication and treatment.


Assuntos
Adenoma/patologia , Neoplasias Nasais/patologia , Idoso , Feminino , Humanos , Cavidade Nasal
15.
Acta Otorrinolaringol Esp ; 49(3): 250-2, 1998 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9644870

RESUMO

A case of cutaneous leishmaniasis that presented as a large cervical ulceration is reported. The etiopathogenesis, clinical manifestations, diagnosis, and treatment are reviewed. The visceral and mucocutaneous forms of the disease were excluded from this study.


Assuntos
Leishmania tropica/isolamento & purificação , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/parasitologia , Pescoço/parasitologia , Idoso , Animais , Feminino , Humanos , Leishmaniose Cutânea/tratamento farmacológico , Meglumina/uso terapêutico
16.
Acta Otorrinolaringol Esp ; 41(2): 96-8, 1990.
Artigo em Espanhol | MEDLINE | ID: mdl-2390302

RESUMO

We display the study performed to a female patient affected of laryngeal paralysis to become, based in clinical and radiologic criteria, to diagnose her cerebellar atrophy. We justify our work because of how infrequently this illness heredodegenerative of the central nervous system begins with cranial pairs paralysis. We emphasize the importance that the new methods of explorations specially TAC and IRM, have to guess the possible etiologies of central originated paralysis.


Assuntos
Atrofias Olivopontocerebelares/complicações , Degenerações Espinocerebelares/complicações , Paralisia das Pregas Vocais/etiologia , Feminino , Humanos , Pessoa de Meia-Idade , Atrofias Olivopontocerebelares/diagnóstico
17.
Sci Total Environ ; 476-477: 276-87, 2014 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-24468502

RESUMO

A partial-nitritation bench-scale submerged biofilter was used for the treatment of synthetic wastewater containing a high concentration of ammonium in order to study the influence of the antibiotic ciprofloxacin on the partial-nitritation process and biodiversity of the bacterial community structure. The influence of ciprofloxacin was evaluated in four partial-nitritation bioreactors working in parallel, which received sterile synthetic wastewater amended with 350 ng/L of ciprofloxacin (Experiment 1), synthetic wastewater without ciprofloxacin (Experiment 2), synthetic wastewater amended with 100 ng/L of ciprofloxacin (Experiment 3) and synthetic wastewater amended with 350 ng/L of ciprofloxacin (Experiment 4). The concentration of 100 ng/L of antibiotics demonstrated that the partial-nitritation process, microbial biomass and bacterial structure generated by tag-pyrosequencing adapted progressively to the conditions in the bioreactor. However, high concentrations of ciprofloxacin (350 ng/L) induced a decay of the partial-nitritation process, while the total microbial biomass was increased. Within the same experiment, the bacterial community experienced sequential shifts with a clear reduction of the ammonium oxidation bacteria (AOB) and an evident increase of Commamonas sp., which have been previously reported to be ciprofloxacin-resistant. Our study suggests the need for careful monitoring of the concentration of antibiotics such as ciprofloxacin in partial-nitritation bioreactors, in order to choose and maintain the most appropriate conditions for the proper operation of the system.


Assuntos
Antibacterianos/toxicidade , Reatores Biológicos/microbiologia , Ciprofloxacina/toxicidade , Nitrificação/efeitos dos fármacos , Eliminação de Resíduos Líquidos/métodos , Bactérias/metabolismo , Biodiversidade , Biomassa , Águas Residuárias/química , Águas Residuárias/microbiologia , Poluentes Químicos da Água/toxicidade
20.
Horm Res Paediatr ; 74(2): 114-20, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20395659

RESUMO

BACKGROUND/AIMS: Contradictory results regarding the optimal initial dose of levothyroxine in children with congenital hypothyroidism (CH) hamper the clinical management of these children during their early infancy. We explore the relationships between the initial dose of levothyroxine and endocrine control during the first 6 months and cognition at school age. SUBJECTS AND METHODS: Fifty children with CH, 14 boys (10+/-3.1 years) and 36 girls (9.7+/-2.6 years), at the Pediatric Endocrine Unit of the Hospital Gregorio Marañón in Madrid were studied. Neurocognitive evaluation was carried out exploring alertness and inhibitory control. The number of episodes of overtreatment during the first 6 months, the initial dose of levothyroxine, etiology and sex were the predictor variables. RESULTS: Inhibitory control was significantly lower in children with CH than in controls. An interaction with gender and etiology was obtained. Alertness had an inverse relationship with the number of episodes of overtreatment with no interaction with gender or etiology. CONCLUSION: Episodes of overtreatment and not the initial dose of levothyroxine are a risk factor for deficit in alertness whereas subtle inhibitory control deficit seems to be a permanent problem with the current therapeutic approach.


Assuntos
Hipotireoidismo Congênito/terapia , Função Executiva/efeitos dos fármacos , Terapia de Reposição Hormonal/métodos , Tiroxina/administração & dosagem , Criança , Hipotireoidismo Congênito/sangue , Hipotireoidismo Congênito/psicologia , Relação Dose-Resposta a Droga , Feminino , Terapia de Reposição Hormonal/efeitos adversos , Humanos , Lactente , Modelos Lineares , Masculino , Tireotropina/sangue , Tiroxina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA